Virtual Medicinal Product (VMP)
-
Hepatitis B immunoglobulin human 500units/5ml solution for injection vials
Name Details
Current Name
Hepatitis B immunoglobulin human 500units/5ml solution for injection vials
|
Start Date
07-11-2023
|
End Date
|
Previous Name
Hepatitis B immunoglobulin human 500unit solution for injection vials
|
Start Date
18-06-2004
|
End Date
06-11-2023
|
|
Abbreviated Name
Hepatitis B immunoglobulin human 500units/5ml inj vials
|
Start Date
07-11-2023
|
|
Hepatitis B immunoglobulin human 500unit inj vials |
Previous Start Date
01-05-2009
|
Previous End Date
06-11-2023
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular, solutioninjection.intramuscular-deep
- Name Basis
- Other
Codes
- ATC Code
-
J06BB04
BNF |
Current BNF
14050200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
14050200
|
Start Date
06-11-2009
|
End Date
03-04-2022
|
Previous BNF
14050000
|
Start Date
22-02-2005
|
End Date
05-11-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39715511000001105 |
26-05-2021 |
|
333774004 |
12-11-2003 |
25-05-2021 |
VMP Ingredients
Name
Hepatitis B immunoglobulin human
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
1
Virtual Medicinal Product Pack (VMPP) Information